Published in Women's Health Weekly, November 28th, 2002
Projected medical cost savings of $32.3 million would offset the extra cost of testing.
It is estimated that in 2001 only 12% (or 1.8 million of 14.9 million) of women aged 65 and older with osteoporosis or osteopenia (low bone mass) received a Medicare-reimbursed BMD test to detect the disease. The study presented October 25, 2002, projected that testing 180,000 (or just 10%)...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly